Companies / Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences
Nasdaq: OACCCIK 2029769LOS ANGELES, CA
Financials
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC 10% owner | Other Derivative conversion | Class A ordinary shares | $339.8K | +34K +6.18% | 583,981 2.38% of shares | low |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC 10% owner | Other Derivative conversion | Private placement units (obligation to buy) | — | -34K -100.00% | 0 0.00% of shares | low |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC 10% owner | Other Derivative conversion | Private placement warrants | — | +7K +6.18% | 116,796 0.48% of shares | low |
| Oct 30, 2024 | Oaktree Acquisition Holdings III LS, LLC 10% owner | Other Other (per filing) | Class B ordinary shares | — | -231K -4.60% | 4,799,758 19.52% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| OACC | common | G6717R104 |